Page 12 - ப்ரெஸ்பிடீரியந் கொலம்பியா பல்கலைக்கழகம் இவிஂக் மருத்துவ மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Biocept Reports 2020 Fourth Quarter and Full Year Financial Results
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
AstraZeneca COVID-19 vaccine trial data questioned; antibody cocktail reduces hospitalizations, deaths: Coronavirus update for Wednesday, March 24
cleveland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cleveland.com Daily Mail and Mail on Sunday newspapers.
March 17, 2021
Three-year outcomes from COMPARE-ABSORB hint that the increased risks of thrombosis and target lesion failure with the now-discontinued Absorb bioresorbable scaffold (Abbott Vascular) do not continue to rise over time.
Rates of target-vessel MI and definite/probable scaffold thrombosis are significantly higher for the investigational device as compared with the metallic everolimus stent, but both risks appear to occur in the early period after device implantation, new data show. In a landmark analysis from 1 to 3 years, there was no significant difference in the risk of target lesion failure, target-vessel MI, or definite/probable scaffold thrombosis between the two devices.
Gene therapy trial for age-related macular degeneration now open at Columbia
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
Unlocking the Mysteries of Long COVID Meghan O Rourke
Photographs by Jonno Rattman
Image above: Nearly a year after she was infected with the coronavirus, Caitlin Barber still uses a wheelchair outside.
This article was published online on March 8, 2021.
The quest at Mount Sinai began with a mystery. During the first wave of the coronavirus pandemic in New York City, Zijian Chen, an endocrinologist, had been appointed medical director of the hospital’s new Center for Post-COVID Care, dedicated both to research and to helping recovering patients “transition from hospital to home,” as Mount Sinai put it. One day last spring, he turned to an online survey of COVID‑19 patients who were more than a month past their initial infection but still experiencing symptoms. Because COVID‑19 was thought to be a two-week respiratory illness, Chen anticipated that he would find only a small number of people who were still sick. That’s not what he saw.